Parallax Volatility Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,161
Closed -$5.45M 1542
2024
Q4
$5.45M Sell
23,161
-3,374
-13% -$887K 0.12% 792
2024
Q3
$7.3M Buy
+26,535
New +$6.91M 0.19% 659
2024
Q2
Sell
-2,237
Closed -$334K 1982
2024
Q1
$334K Buy
+2,237
New +$373K 0.01% 1483
2023
Q1
Hold
0
2698
2022
Q4
Hold
0
2861
2022
Q3
Sell
-12,781
Closed -$1.86M 3049
2022
Q2
$1.86M Buy
+12,781
New +$1.81M ﹤0.01% 1382
2020
Q4
Sell
-15,460
Closed -$2.25M 2276
2020
Q3
$2.25M Buy
15,460
+11,746
+316% +$1.67M 0.02% 1640
2020
Q2
$550K Buy
3,714
+2,260
+155% +$305K 0.01% 1944
2020
Q1
$158K Sell
1,454
-1,250
-46% -$144K ﹤0.01% 2034
2019
Q4
$311K Buy
+2,704
New +$270K ﹤0.01% 1894
2019
Q3
Sell
-157
Closed -$11K 2282
2019
Q2
$11K Sell
157
-28
-15% -$2.15K ﹤0.01% 2157
2019
Q1
$17K Sell
185
-4,046
-96% -$338K ﹤0.01% 2515
2018
Q4
$308K Sell
4,231
-596
-12% -$45.8K 0.01% 1634
2018
Q3
$422K Sell
4,827
-6,714
-58% -$675K 0.01% 1471
2018
Q2
$1.14M Buy
+11,541
New +$1.14M 0.04% 1064
2018
Q1
Sell
-299
Closed -$38K 2188
2017
Q4
$38K Sell
299
-45,091
-99% -$5.67M ﹤0.01% 3359
2017
Q3
$5.33M Buy
+45,390
New +$3.87M 0.2% 553
2017
Q2
Hold
0
2199
2015
Q4
Sell
-1,500
Closed -$121K 2847
2015
Q3
$121K Hold
1,500
﹤0.01% 1953
2015
Q2
$180K Buy
+1,500
New +$179K 0.01% 2033

Other funds holding ALNY